Inhibitors of poly(ADP-ribose) polymerase (PARP) [NEW TOPIC PAGE]

https://phgkb.cdc.gov/GAPPKB/phgHome.do

From HuGE Literature Finder Database

This database contains published literature on genetic associations and other human genome epidemiology

---

• Analysis Suggests Wider Use for PARP Inhibitors.  
  Cancer discovery 2017 Apr .
  Authors are not available
• Poly (ADP-Ribose) Polymerase-1 (PARP-1) in Chinese patients with Graves Disease and Graves Ophthalmopathy.  
  Canadian journal of physiology and pharmacology 2017 Jan .
  Wu Tong, Tang Dong-Run, Zhao Liang, Sun Feng-Yu
• Associations of PARP-1 variant rs1136410 with PARP activities, oxidative DNA damage, and the risk of age-related cataract in a Chinese Han population: A two-stage case-control analysis.  
  Gene 2016 Nov .
  Cui Ning-Hua, Qiao Chen, Chang Xiao-Ke, Wei
• Effect of Itraconazole and Rifampin on the Pharmacokinetics of Olaparib in Patients With Advanced Solid Tumors: Results of Two Phase I Open-Label Studies.  
  Clinical therapeutics 2016 Oct .
  Dirix Luc, Swaisland Helen, Verheul Henk M W, Rottey Sylvie, Leunen Karin, Jerusalem Guy, Rolfo Christian, Nielsen Dorte, Molife L Rhoda, Kristeleit Rebecca, Vos-Geelen Judith de, Mau-Sørensen Morten, Soetekouw Patricia, van Herpen Carla, Fielding Anitra, So Karen, Bannister Wendy, Plummer Ru
• Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer.  
  The New England journal of medicine 2016 Oct .
  Mirza Mansoor R, Monk Bradley J, Herrstedt Jørn, Oza Amit M, Mahner Sven, Redondo Andrés, Fabbro Michel, Ledermann Jonathan A, Lorusso Domenica, Vergote Ignace, Ben-Baruch Noa E, Marth Christian, M?dry Rados?aw, Christensen René D, Berek Jonathan S, Dørum Anne, Tinker Anna V, du Bois Andreas, González-Martín Antonio, Follana Philippe, Benigno Benedict, Rosenberg Per, Gilbert Lucy, Rimel Bobbie J, Buscema Joseph, Balser John P, Agarwal Shefali, Matulonis Ursula A,

more